Доступ предоставлен для: Guest
Journal of Environmental Pathology, Toxicology and Oncology
Главный редактор: Qian Peng (open in a new tab)

Выходит 4 номеров в год

ISSN Печать: 0731-8898

ISSN Онлайн: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

Photodynamic Therapy and Detection of High-Grade Gliomas

Том 25, Выпуск 1-2, 2006, pp. 453-466
DOI: 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.290
Get accessGet access

Краткое описание

The first reported use of photodynamic therapy (PDT) for the treatment of high-grade gliomas occurred in 1981. In the intervening years there have been relatively few clinical trials to investigate the efficacy of this therapeutic modality for the treatment of gliomas. This is due, in part, to the rarity of the disease, and the ever growing list of novel therapies that PDT must compete against. These factors make accrual of patients for clinical trials a difficult proposition. During the mid-1990s, a number of reviews were published that effectively summarized the status of PDT for the management of high-grade gliomas. The intent of the present work is to provide an update of recent developments (1996−2004) in PDT and photodynamic detection (PDD) of gliomas, in particular, glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA).

ЦИТИРОВАНО В
  1. Peng Qian, Juzeniene Asta, Chen Jiyao, Svaasand Lars O, Warloe Trond, Giercksky Karl-Erik, Moan Johan, Lasers in medicine, Reports on Progress in Physics, 71, 5, 2008. Crossref

  2. Hirschberg Henry, Lasers in Diagnostics and Treatment of Brain Diseases, in Biomedical Photonics Handbook, Second Edition, 2014. Crossref

  3. Stummer Walter, Beck Tobias, Beyer Wolfgang, Mehrkens Jan Hendrik, Obermeier Andreas, Etminan Nima, Stepp Herbert, Tonn Jörg-Christian, Baumgartner Reinhold, Herms Jochen, Kreth Friedrich Wilhelm, Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report, Journal of Neuro-Oncology, 87, 1, 2008. Crossref

  4. Rozhkova Elena A., Nanoscale Materials for Tackling Brain Cancer: Recent Progress and Outlook, Advanced Materials, 23, 24, 2011. Crossref

  5. Yip Stephen, Shah Khalid, Optical Imaging of Cancer: Neuro-oncologic Applications, in Optical Imaging of Cancer, 2010. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain